Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Kodiak Gas Services stock jumps on $675 million DPS buy as data-center power demand bites

Kodiak Gas Services stock jumps on $675 million DPS buy as data-center power demand bites

Kodiak Gas Services shares rose 4.2% to $49.29 after announcing a $675 million acquisition of Distributed Power Solutions, funded by $575 million in cash and $100 million in stock. The deal, expected to close in early Q2 2026, awaits antitrust approval and hinges on Kodiak maintaining leverage targets. Investors await further details at the Feb. 26 earnings call.
Regal Rexnord stock ticks higher after $735 million data-center orders put 2026 outlook in play

Regal Rexnord stock ticks higher after $735 million data-center orders put 2026 outlook in play

Regal Rexnord shares rose 1.4% to $202.75 Friday after posting fourth-quarter adjusted earnings of $2.51 per share and 2026 guidance of $10.20–$11.00 EPS. The company reported $735 million in E-Pod orders tied to data-center power projects, with first shipments expected in 2027. Revenue for the quarter was about $1.52 billion. Management flagged weak residential HVAC demand and uncertainty in converting backlog to revenue.
Kulicke & Soffa stock price today: KLIC steadies premarket after 19% earnings jump, Needham lifts target

Kulicke & Soffa stock price today: KLIC steadies premarket after 19% earnings jump, Needham lifts target

Kulicke & Soffa shares rose 0.4% to $66.66 in premarket trading Friday after a 19.3% surge Thursday, following upbeat Q2 revenue guidance of around $230 million. Fiscal Q1 net revenue reached $199.6 million, with utilization rates topping 80% in general semiconductors. Needham raised its price target to $70. The company filed its latest 10-Q on Thursday.
McKesson stock steadies after post-earnings surge as Wall Street rechecks the playbook

McKesson stock steadies after post-earnings surge as Wall Street rechecks the playbook

McKesson shares slipped 0.1% to $956.71 in early New York trading Friday after a 16.5% surge the previous session. The company raised its fiscal 2026 adjusted earnings guidance to $38.80-$39.20 per share and confirmed plans to spin off its medical-surgical unit with an IPO targeted for late 2027. Fiscal Q3 revenue rose 11% to $106.2 billion.
Phibro Animal Health stock hovers near $50 before the bell after a 22% earnings surge

Phibro Animal Health stock hovers near $50 before the bell after a 22% earnings surge

Phibro Animal Health shares were flat in premarket trading Friday after a 22% jump to a 52-week high on Thursday. The company raised its fiscal 2026 sales and profit forecasts following a 21% rise in quarterly net sales to $373.9 million and adjusted EPS of $0.87. Phibro will pay a $0.12 per share dividend on March 25 to holders as of March 4.
FormFactor stock holds near $84 after earnings beat — what FORM investors watch next

FormFactor stock holds near $84 after earnings beat — what FORM investors watch next

FormFactor shares were flat in premarket trading Friday after a 17% jump on Thursday, closing at $83.87. The company posted record quarterly revenue of $215.2 million and GAAP net income of $23.2 million. Management raised guidance for the March quarter and set May 11 as its next Analyst Day. CFO Aric McKinnis said margin gains outpaced expectations but warned tariffs continue to weigh on results.
SiTime stock jumps premarket as $3.2 billion Renesas timing deal keeps SITM in play

SiTime stock jumps premarket as $3.2 billion Renesas timing deal keeps SITM in play

SiTime shares rose 3.3% in premarket trading Friday after announcing a $1.5 billion cash-and-stock deal to acquire Renesas’ timing business. The company reported $113.3 million in fourth-quarter revenue, up 66% year-over-year, and issued a positive forecast for the first quarter. SiTime expects the acquired unit to add $300 million in revenue within a year of closing.
AMD stock rebounds before the bell after brutal selloff as China supply worries surface

AMD stock rebounds before the bell after brutal selloff as China supply worries surface

AMD shares rose about 4% in premarket trading Friday, rebounding after a two-day slide erased over 20% of its value. The company forecast Q1 revenue near $9.8 billion, about 5% below the previous quarter, and warned Chinese clients of server CPU supply delays. AMD’s stock hovered near $200 after closing at $192.50 Thursday. Uncertainty remains over U.S. export licenses for China-bound AI chips.
Bradesco shares slide as Banco Bradesco maps 2026 growth after Q4 profit

Bradesco shares slide as Banco Bradesco maps 2026 growth after Q4 profit

Bradesco’s preferred shares fell 4.5% to 20.19 reais in Sao Paulo after the bank posted a fourth-quarter recurring net income of 6.5 billion reais and outlined 2026 growth targets. The bank expects loan growth of 8.5%–10.5% and net interest income after provisions of up to 48 billion reais. Investors are watching credit costs and expenses linked to Bradesco’s ongoing restructuring.
CCC Intelligent Solutions stock price whipsaws: premarket bounce follows 13% slide as GM lawsuit surfaces

CCC Intelligent Solutions stock price whipsaws: premarket bounce follows 13% slide as GM lawsuit surfaces

CCC Intelligent Solutions shares rose 1.2% to $5.75 in premarket trading Friday after plunging 12.6% the previous session. Court records show General Motors sued CCC and others in a U.S. design-patent case. CCC also announced expanded access to its estimating software for collision-repair schools following a new workforce study. Quarterly results are due Feb. 24.
Pfizer stock slips before open as TrumpRx discounts debut and FDA priority review adds a catalyst

Pfizer stock slips before open as TrumpRx discounts debut and FDA priority review adds a catalyst

Pfizer shares fell 1.1% to $26.49 in premarket trading after the TrumpRx discount drug portal launched Thursday, raising concerns over U.S. drug pricing. Pfizer said its TrumpRx program offers discounts of up to 85% on more than 30 medicines. The FDA granted Priority Review for expanding Hympavzi use in younger hemophilia patients, with a decision expected in the second quarter.
1 5 6 7 8 9 882

Stock Market Today

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

7 February 2026
ST Engineering shares fell 1.9% to S$9.71 Friday, outpacing the Singapore market’s 0.8% drop amid a tech-led selloff. The company signed a deal with Shield AI at the Singapore Airshow to integrate autonomy software into its unmanned platforms and unveiled a small drone capable of carrying explosives. About 6.9 million shares traded as investors await full-year results on Feb. 27.
Go toTop